• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Procalcitonin for diagnosing and monitoring bacterial infections: for or against?

作者信息

Lippi Giuseppe, Cervellin Gianfranco

机构信息

Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37100 - Verona, Italy.

Emergency Department, University Hospital of Parma, Parma, Italy.

出版信息

Clin Chem Lab Med. 2018 Jul 26;56(8):1193-1195. doi: 10.1515/cclm-2018-0312.

DOI:10.1515/cclm-2018-0312
PMID:29702485
Abstract
摘要

相似文献

1
Procalcitonin for diagnosing and monitoring bacterial infections: for or against?降钙素原用于诊断和监测细菌感染：支持还是反对？
Clin Chem Lab Med. 2018 Jul 26;56(8):1193-1195. doi: 10.1515/cclm-2018-0312.
2
How to use… Procalcitonin.如何使用……降钙素原。
Arch Dis Child Educ Pract Ed. 2018 Oct;103(5):257-262. doi: 10.1136/archdischild-2017-313699. Epub 2018 Jan 17.
3
Procalcitonin as a diagnostic marker for differentiating DRESS syndrome from bacterial infection.降钙素原作为鉴别药物超敏反应综合征与细菌感染的诊断标志物。
Ann Allergy Asthma Immunol. 2019 Sep;123(3):307-309.e1. doi: 10.1016/j.anai.2019.06.017. Epub 2019 Jun 22.
4
Use of procalcitonin as a tool for antibiotic stewardship.使用降钙素原作为抗生素管理的工具。
Future Microbiol. 2019 Jan;14:77-79. doi: 10.2217/fmb-2018-0326. Epub 2019 Jan 15.
5
Does Procalcitonin Predict Bacterial Infection in Febrile Children with Sickle Cell Disease?降钙素原能否预测镰状细胞病发热儿童的细菌感染？
Indian J Pediatr. 2019 Jan;86(1):95-96. doi: 10.1007/s12098-018-2717-x. Epub 2018 Jun 23.
6
Procalcitonin use in the presence of ambiguous physiological parameters: a help or a hindrance on the acute medical unit?在生理参数不明确的情况下使用降钙素原：对急性内科病房是帮助还是阻碍？
J Hosp Infect. 2020 Mar;104(3):395-396. doi: 10.1016/j.jhin.2019.11.003. Epub 2019 Nov 15.
7
Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.在急诊科使用 C 反应蛋白、降钙素原、TRAIL 和 IP-10 联合检测识别细菌感染患者：一项前瞻性观察队列研究。
Clin Microbiol Infect. 2018 Dec;24(12):1297-1304. doi: 10.1016/j.cmi.2018.09.007. Epub 2018 Sep 28.
8
Procalcitonin as a biomarker for diagnose of bacterial infection in patients with acute-on-chronic liver failure.降钙素原作为诊断慢性肝衰竭急性发作患者细菌感染的生物标志物。
Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):e32-e34. doi: 10.1016/j.clinre.2019.06.011. Epub 2019 Jul 11.
9
Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.降钙素原监测在抗菌治疗中的指导作用：文献复习。
Pharmacotherapy. 2018 May;38(5):569-581. doi: 10.1002/phar.2112. Epub 2018 Apr 23.
10
Excluding Severe Bacterial Infection in Neutrophilic Dermatoses with Systemic Manifestations: Negative Predictive Value of Procalcitonin.排除伴有全身表现的嗜中性皮病中的严重细菌感染：降钙素原的阴性预测价值
Ann Acad Med Singap. 2018 Mar;47(3):123-126.

引用本文的文献

1
Cost-effectiveness of Procalcitonin (PCT) guidance for antibiotics management of adult sepsis patients in the Egyptian context.降钙素原（PCT）指导埃及成人脓毒症患者抗生素管理的成本效益。
BMC Health Serv Res. 2024 Oct 17;24(1):1249. doi: 10.1186/s12913-024-11675-9.
2
Predictive markers related to local and systemic inflammation in severe COVID-19-associated ARDS: a prospective single-center analysis.与严重 COVID-19 相关 ARDS 局部和全身炎症相关的预测标志物：一项前瞻性单中心分析。
BMC Infect Dis. 2023 Jan 11;23(1):19. doi: 10.1186/s12879-023-07980-z.
3
Determining laboratory parameters in pregnant women with severe COVID-19.
确定患有重症新型冠状病毒肺炎的孕妇的实验室参数。
SAGE Open Med. 2022 Oct 18;10:20503121221132168. doi: 10.1177/20503121221132168. eCollection 2022.
4
Seroprevalence of community-acquired atypical bacterial pneumonia among adult COVID-19 patients from a single center in Al Madinah Al Munawarah, Saudi Arabia: A retrospective cohort study.沙特阿拉伯麦地那市单一中心成年 COVID-19 患者获得性非典型细菌性肺炎血清流行率：一项回顾性队列研究。
Saudi Med J. 2022 Sep;43(9):1000-1006. doi: 10.15537/smj.2022.43.9.20220379.
5
Potential role of biochemical markers in the prognosis of COVID-19 patients.生化标志物在COVID-19患者预后中的潜在作用。
SAGE Open Med. 2022 Jul 5;10:20503121221108613. doi: 10.1177/20503121221108613. eCollection 2022.
6
Is cardiac Troponin I Considered as A Predictor of In-hospital Mortality among COVID-19 Patients? A Retrospective Cohort Study.心肌肌钙蛋白I是否被视为COVID-19患者院内死亡率的预测指标？一项回顾性队列研究。
Bull Emerg Trauma. 2022 Jan;10(1):9-15. doi: 10.30476/BEAT.2022.92719.1310.
7
The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.COVID-19 住院患者的炎症生物标志物特征及其与患者预后的关系：一项单中心研究。
PLoS One. 2021 Dec 2;16(12):e0260537. doi: 10.1371/journal.pone.0260537. eCollection 2021.
8
Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients.评估血清降钙素原水平作为COVID-19患者疾病严重程度生物标志物的价值。
New Microbes New Infect. 2021 Sep;43:100922. doi: 10.1016/j.nmni.2021.100922. Epub 2021 Jul 24.
9
The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.2019冠状病毒病（COVID-19）患者炎症标志物的动态变化：一项系统评价和荟萃分析。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100727. doi: 10.1016/j.cegh.2021.100727. Epub 2021 Mar 20.
10
Procalcitonin levels in COVID-19 patients.COVID-19 患者降钙素原水平。
Int J Antimicrob Agents. 2020 Aug;56(2):106051. doi: 10.1016/j.ijantimicag.2020.106051. Epub 2020 Jun 10.